— Know what they know.
Not Investment Advice
Also trades as: EVT.DE (XETRA) · $vol 3M · EVT.SW (SIX) · $vol 1M · 0IRF.IL (IOB) · $vol 0M · EVOTF (OTC) · $vol 0M

EVO NASDAQ

Evotec SE
1W: +2.6% 1M: -15.8% 3M: -45.2% YTD: -49.7% 1Y: -57.5% 3Y: -83.4% 5Y: -93.9%
$1.60
-0.04 (-2.74%)
 
Weekly Expected Move ±5.9%
$1 $2 $2 $2 $2
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 34 · $568.4M mcap · 337M float · 0.023% daily turnover · Short 42% of daily vol

Revenue Segmentation

By Product / Service

Income Trends

Revenue
$797M +2.0% ▲
5Y CAGR: +12.3%
Gross Profit
$115M -34.4% ▼
5Y CAGR: -2.9%
Operating Income
-$143M -200.0% ▼
Net Income
-$196M -133.7% ▼
EPS (Diluted)
$-0.56 -136.2% ▼
EBITDA
-$81M -434.3% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$501M$618M$751M$781M$797M
YoY Growth+12.2%+23.4%+21.6%+4.0%+2.0%
Cost of Revenue$375M$466M$577M$606M$682M
Gross Profit$126M$152M$174M$175M$115M
Gross Margin25.1%24.5%23.2%22.4%14.4%
R&D Expenses$60M$66M$77M$69M$51M
SG&A Expenses$77M$105M$156M$170M$188M
Operating Expenses$77M$111M$153M$223M$257M
Operating Income$49M$41M$21M-$48M-$143M
Operating Margin9.7%6.6%2.8%-6.1%-17.9%
Interest Expense$8M$9M$13M$12M$12M
Income Before Tax$26M$237M-$154M-$81M-$194M
Tax Expense$20M$21M$22M$3M$2M
Net Income$6M$216M-$176M-$84M-$196M
Net Margin1.3%34.9%-23.4%-10.7%-24.6%
EPS (Diluted)$0.02$0.65$-0.49$-0.23$-0.56
EBITDA$90M$317M-$58M$24M-$81M
Shares Outstanding308M333M353M354M355M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms